If you are considering a GLP-1 medication or have recently started treatment, understanding possible side effects is part of making an informed decision. Some people experience digestive symptoms, while others may need a treatment adjustment or medical evaluation.
At OTR Health & Wellness in Cumming, GA, medication decisions begin with an individualized assessment. Your medical history, current medications, treatment goals, and potential risks all matter when determining whether a prescription is appropriate.
This article offers general information. Your medication’s current Medication Guide and your prescribing clinician’s instructions should guide your care.
Understanding GLP-1 Medications
GLucagon-like peptide-1 receptor agonists, commonly called GLP-1 medications, affect pathways involved in blood sugar regulation, appetite, and digestion. Certain products are FDA-approved for type 2 diabetes, while others have specific weight-management indications. Approval applies to the particular product and use; medications in this class are not interchangeable.
For example, Wegovy® contains semaglutide and has approved weight-management uses for eligible patients alongside nutrition and physical activity measures. A prescription requires an assessment of the product’s indications, contraindications, and potential risks. accessdata.fda.gov
Common Side Effects
Depending on the medication, side effects may include:
Nausea or vomiting.
Diarrhea or constipation.
Abdominal discomfort, bloating, or indigestion.
Heartburn or burping.
Headache, fatigue, or dizziness.
Digestive symptoms may occur when treatment begins or the dose increases. Their severity and duration vary. Symptoms should not automatically be dismissed as a normal adjustment, particularly when they interfere with eating, drinking, or daily activities. accessdata.fda.gov
Reduced appetite can also make it harder to meet nutritional needs. Tell your clinician if you are regularly skipping meals, struggling to eat enough, or feeling persistently weak.
Managing Mild Symptoms With Your Provider’s Guidance
For mild symptoms, your clinician may recommend changes to eating habits, fluid intake, or the treatment schedule. These strategies should support adequate nutrition and hydration.
Eat smaller portions and stop when comfortably satisfied. Eating slowly and avoiding large meals may help reduce discomfort. If greasy, rich, or spicy foods worsen symptoms, discuss suitable alternatives.
Drink fluids regularly. Small, frequent sips may be easier to tolerate when you feel nauseated. Ask about appropriate fluid intake if you have kidney disease, heart disease, or a prescribed fluid restriction.
Ask about constipation management. Your provider may suggest gradual dietary changes, fluids, or activity appropriate to your health. Check before starting laxatives or supplements.
Keep a symptom record. Note when symptoms occur, how long they last, and whether you can eat and drink normally. Share this information before a planned dose increase.
Follow the prescribed schedule. Do not increase your dose early, take extra medication, or change the schedule yourself. Contact your prescriber if symptoms persist or you are uncertain about the next dose.
These measures do not replace medical assessment for severe or worsening symptoms.
Symptoms That Need Prompt Medical Attention
Warnings differ among products. The following examples are important risks described in semaglutide prescribing information and are not a complete list.
Severe or persistent abdominal pain: Pain that may spread to the back, with or without vomiting, can indicate pancreatitis. Stop the medication and seek immediate medical evaluation if these symptoms occur.
Possible gallbladder problems: Upper abdominal pain, fever, yellowing of the skin or eyes, or pale stools require prompt assessment.
Dehydration or kidney problems: Repeated vomiting or diarrhea, inability to keep fluids down, or substantially reduced urination warrant urgent medical advice.
Severe digestive symptoms: Persistent vomiting, marked abdominal swelling, or severe constipation with pain should not be managed with dietary changes alone.
A serious allergic reaction: Stop the medication and call 911 for trouble breathing or swallowing, swelling of the face, lips, tongue, or throat, or collapse.
Low blood sugar: Risk can increase when certain GLP-1 medications are combined with insulin or sulfonylureas. Follow your prescribed low-blood-sugar plan. Call 911 for unconsciousness, seizures, or severe confusion.
Changes in vision: Report new or worsening vision symptoms promptly, especially if you have diabetes or diabetic retinopathy. accessdata.fda.gov
Do not wait for a routine follow-up appointment when symptoms are severe.
Understanding the Thyroid Tumor Warning
Certain GLP-1 medications carry a boxed warning about thyroid C-cell tumors observed in rodents. It is not known whether these medications cause these tumors in humans. Describing thyroid cancer as an established, rare human side effect would misrepresent that uncertainty.
For products such as Wegovy®, a personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia syndrome type 2 (MEN 2), is a contraindication. Tell your clinician about these conditions before treatment.
A neck lump, persistent hoarseness, or difficulty swallowing should also be evaluated. Trouble breathing requires emergency care. accessdata.fda.gov
Information to Share Before Starting Treatment
A thorough medication review helps your clinician assess suitability. Discuss:
All prescriptions, over-the-counter medications, and supplements.
Previous pancreatitis, gallbladder disease, kidney problems, or severe digestive conditions.
Diabetes, diabetic eye disease, and medications that lower blood sugar.
Previous serious medication reactions.
Pregnancy, pregnancy plans, or breastfeeding.
Any upcoming procedure involving anesthesia or deep sedation.
Some products have pregnancy-related precautions and may be unsuitable for people with severe gastroparesis. Delayed stomach emptying can also create concerns during anesthesia. Tell your surgical and anesthesia teams about your medication and follow their individualized instructions. accessdata.fda.gov
FDA-Approved and Compounded Products Are Different
Compounded GLP-1 products are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality before marketing, and they should not be described as FDA-approved generics or equivalent versions of approved medications.
The FDA has also reported dosing errors involving compounded injectable semaglutide. If prescribed a compounded product, make sure the prescriber and pharmacist clearly explain the concentration, prescribed dose, measuring device, and administration instructions. Never guess or copy another person’s instructions. FDA
Discuss Your Questions With OTR Health & Wellness
Side effects deserve attention throughout treatment. Follow-up visits provide an opportunity to review symptoms, nutrition, medication tolerance, and whether continuing treatment remains appropriate.
At OTR Health & Wellness in Cumming, GA, a consultation can help you discuss medical weight-management options and the evaluation needed before prescribing. No medication is appropriate for everyone, and treatment outcomes are not guaranteed.
Contact OTR Health & Wellness to schedule an individualized consultation about weight management, medication risks, and ongoing monitoring.
This article provides general educational information and is not a substitute for individualized medical advice, diagnosis, or treatment. Prescription medications require evaluation by a licensed healthcare professional. Eligibility, side effects, and results vary. Follow your medication’s current Medication Guide and your prescriber’s instructions. Seek immediate medical care for severe symptoms.